FRUQUINTINIB for Rectosigmoid cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 71 adverse event reports in the FDA FAERS database where FRUQUINTINIB was used for Rectosigmoid cancer.

Most Reported Side Effects for FRUQUINTINIB

Side Effect	Reports	%	Deaths	Hosp.
Death	647	25.2%	647	79
Fatigue	366	14.3%	104	96
Colon cancer	277	10.8%	53	37
Blood pressure increased	223	8.7%	49	74
Diarrhoea	213	8.3%	52	80
Colorectal cancer metastatic	212	8.3%	53	20
Decreased appetite	184	7.2%	55	77
Asthenia	178	6.9%	51	66
Dysphonia	176	6.9%	45	53
Off label use	133	5.2%	32	67
Nausea	132	5.2%	46	49
Myelosuppression	122	4.8%	1	74
Pain	117	4.6%	31	48
Hypertension	115	4.5%	10	32
Product dose omission issue	94	3.7%	23	33